Thanks everybody!

Hi
I just saw this thread. A month ago, there was a request for application (RFA) posted by Andy Grove's research foundation (cannot remember its name) precisely for the topic of objective measurements for PD. That foundation would be the best to send your proposal to. If you are looking for angel funding, send me a message, I have some useful information that I can share with you.
Good Luck and hope your project gets funded.

Girija

Rfa
 

ent????
Girija

RFA from the Kinetics Foundation

Help test the value of objective measurements for PD, and receive free equipment and support for your trial or study!

Measurements that are both objective and precise are in critical need in the development of new treatments for Parkinson's Disease, particularly with the evaluation of neuroprotective therapies.

The Kinetics Foundation has supported the development and validation of the OPDM (Objective Parkinson's Disease Measurement) System, consisting of two different input devices and a back-end data server, and is now making these integrated systems available to the research community. The system was developed and validated at Academic Centers including Oregon Health Science University and Portland State University and have been used at a number of supporting institutions including the NIH, UCSF, and Rush University Medical Center; created in part through collaboration with Intel.

Call to Action: While the OPDM system has shown good promise, it is new to the Parkinson's community at large. The Kinetics Foundation has offered to provide free systems, as well as some funds for third party costs of patient participants. Their goal is to accelerate the adoption of objective measurement devices by providing the OPDM System to studies and trials that would benefit from features like increased precision and more frequent measurements.

Systems are limited, so those wishing to receive them must submit a brief online application, explaining how their study would benefit from using the system, and agree to publicly share the results they obtain from the use of the devices (e.g. journal publication, pdonlineresearch.org).

The OPDM-Dexterity can be used in clinic and/or at home, the OPDM-Mobility is clinic-only; any proposed combination of devices and locations will be considered.

We will have representatives at the MDS Congress in Buenos Aries; for more information, including how to apply, contact OPDM@kineticsfoundation.org. Please include information regarding your trial, including the number of subjects you would like to test. More information will be made available online by July 1, 2010. Submissions will be due by August 1, 2010. Winners of these systems, and the financial support that accompanies them, will be announced by September 1, 2010.
girija